Extended Cycle Approaches While standard protocols recommend 8-12 week cycles, some experienced researchers run longer cycles of 16-20 weeks based on GHK-Cus apparent lack of tolerance development
Tirzepatide is a novel glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for the treatment of type 2 diabetes mellitus under the brand name Mounjaro, and for chronic weight management as Zepbound
During your consultation, we review your medical history, symptoms, and objectiveswhether its boosting immunity, enhancing skin radiance, accelerating recovery, or detoxificationto recommend a personalised vitamin IV drip formula tailored specifically for you
Vida Health serves as the provider partner, ensuring members receive evidence-based, clinically appropriate prescriptions